Syringomyelia: Current concepts in pathogenesis, diagnosis, and treatment

Journal of Veterinary Internal Medicine

Volumn 20, Issue 3, 2006, Pages 469-479

  Rusbridge, Clare ^a   Greitz, Dan ^b   Iskandar, Bermans J ^c  

^a Stone Lion Veterinary Centre   (United Kingdom)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c University of Wisconsin Health   (United States)

Author keywords

Cavalier King Charles Spaniel; Chiari malformation; Cine magnetic resonance imaging; Dysesthesia; Medical management; Occipital hypoplasia; Pathophysiology; Suboccipital decompression; Syringohydromyelia; Syrinx

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARNOLD CHIARI MALFORMATION; DECISION TREE; DOG; DOG DISEASE; GENETIC PREDISPOSITION; GENETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PEDIGREE; REVIEW; SYRINGOMYELIA;

ANIMALS; ARNOLD-CHIARI MALFORMATION; DECISION TREES; DOG DISEASES; DOGS; GENETIC PREDISPOSITION TO DISEASE; MAGNETIC RESONANCE IMAGING; PEDIGREE; SYRINGOMYELIA;

EID: 33646840702     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2006)20[469:SCCIPD]2.0.CO;2     Document Type: Review

References (70)

1. Rusbridge C, Knowler SP. Inheritance of occipital bone hypoplasia (Chiari type I malformation) in Cavalier King Charles Spaniels. J Vet Intern Med 2004;18:673-678.
2. Medow J, Sansone J, Iskandar BJ. Syringomyelia and hydromyelia. In: Albright AL, Pollack AF, Adelson PD, eds. Principles and Practice of Pediatric Neurosurgery, 2nd ed. New York, NY: Thieme Medical Publishers. (in press)
3. Stephanus C. De dissections partium corporis humani. Paris: Colinaeum; 1545.
4. Ollivier d'angers CP. Taite de la moelle epiniere et de ses maladies. Paris: Crevot; 1827:178-183.
5. Kahler O, Pick A. Beitrag zur Lehre von der Syringo-und Hydromyelie. Vjschr Prakt Heilkd 1879;142:20-41.
6. Cahrabortty S, Tamaki N, Ehara K, et al. Experimental syringomyelia in the rabbit: An ultrastructural study of spinal cord tissue. Neurosurgery 1994;35:1112-1120.
7. Batzdorf U. A Brief history of syringomyelia. In: Tamaki N, Batzdorf U, Nagashima T, eds. Syringomyelia: Current Concepts in Pathogenesis and Management. Tokyo: Springer-Verlag; 2001:3-9.
8. Milhorat TH, Fox A, Todor DR. Pathology, classification, and treatment of syringomyelia. In: Tamaki N, Batzdorf U, Nagashima T, eds. Syringomyelia: Current Concepts in Pathogenesis and Management. Tokyo: Springer-Verlag; 2001:10-30.
9. West RJ, William B. Radiographic studies of the ventricles in syringomyelia. Neuroradiology 1980;20:5-16.
10. Chiari H. Ueber Veränderungen des Kleinhirns infolge von Hydrocephalie des Grosshirns. Dtsch Med Wochenschir 1891;42:1172-1175.
11. Chiari H. Ueber Veränderungen des Kleinhirns, des Pons and der medulla oblongata in Folge von genitaler Hydrocephalie des Grosshirns. Denkschr Akad Wiss Wien 1896;63:71-116.
12. Batzdorf U. Treatment of syringomyelia associated with Chiari I malformation in syringomyelia. In: Tamaki N, Batzdorf U, Nagashima T, eds. Syringomyelia: Current Concepts in Pathogenesis and Management. Tokyo: Springer-Verlag; 2001:121-123.
13. Williams B. Progress in syringomyelia. Neurol Res 1986;8:130-145.
14. Rusbridge C, MacSweeny JE, Davies JV, et al. Syringomyelia in Cavalier King Charles Spaniels. J Am Anim Hosp Assoc 2000;36:34-41.
15. Dewey CW, Berg JM, Stefanacci JD, et al. Caudal occipital malformation syndrome in dogs. Compend Contin Educ Pract Vet 2004;26:886-896.
16. Greitz D. Radiological assessment of hydrocephalus: new theories and implications for therapy. Neurosurg Rev 2004;27:145-165.
17. Gardner WJ, Goodall RJ. The surgical treatment of Arnold Chiari malformation in adults. An explanation of its mechanism and importance of encephalography in diagnosis. J Neurosurg 1950;7:199-206.
18. Oldfield EH, Murasko K, Shawker TH, et al. Pathophysiology of syringomyelia associated with Chiari I malformation of the cerebellar tonsils. Implications for diagnosis and treatment. J Neurosurg 1994;81:500-502.
19. Williams B. Cerebrospinal fluid changes in response to coughing. Brain 1976;99:331-346.
20. Levine DN. The pathogenesis of syringomyelia associated with lesions at the foramen magnum: A critical review of existing theories and proposal of a new hypothesis. J Neurol Sci 2004;220:3-21.
21. Ball MJ, Dayan AD. Pathogenesis of syringomyelia. Lancet 1972;II:799-801.
22. Ikata T, Masaki K, Kashiwaguchi S. Clinical and experimental studies on permeability of tracers in normal spinal cord and syringomyelia. Spine 1988;13:737-741.
23. Oldfield EH, DeVroom HL, Heiss JD. Hydrodynamics of syringomyelia. In: Tamaki N, Batzdorf U, Nagashima T, eds. Syringomyelia: Current Concepts in Pathogenesis and Management. Tokyo: Springer-Verlag; 2001:75-89.
24. Heiss JD, Patronas N, DeVroom HL, et al. Elucidating the pathophysiology of syringomyelia. J Neurosurg 1999;91:553-562.
25. Williams B. Surgery for cerebello-medullary related syringomyelia. Adv Tech Stand Neurosurg 1993;20:107-164.
26. Greitz D, Ericson K, Flodmark O. Pathogenesis and mechanics of spinal cord cysts: A new hypothesis based on magnetic resonance studies of cerebrospinal fluid dynamics. Int J Neuroradiol 1999;5:61-78.
27. Josephson A, Greitz D, Klason T, et al. A spinal thecal sac constriction model supports the theory that induced pressure gradients in the cord cause edema and cyst formation. Neurosurgery 2001;48:636-646.
28. Greitz D, Flodmark O. Modern concepts of syringohydromyelia. Riv Neuroradiol 2004;17:360-361.
29. Carpenter PW, Berkouk K, Lucey AD. Pressure wave propagation in fluid-filled co-axial elastic tubes. Part 2: Mechanisms for the pathogenesis of syringomyelia. J Biomech Eng 2003;125:857-863.
30. Fischbein NJ, Dillon WP, Cobbs C, et al. The "presyrinx" state. A reversible myelopathic condition that may precede syringomyelia. AJNR Am J Neuroradiol 1999;20:7-20.
31. Iskandar BJ, Quigley M, Haughton VM. Foramen magnum cerebrospinal fluid flow characteristics in children with Chiari 1 malformation before and after craniocervical decompression. J Neurosurg (Paediatrics 2) 2004;101:169-178.
32. Hackel M, Benes V, Mohapl M. Simultaneous cerebral and spinal fluid pressure recordings in surgical indications of the Chiari malformation without myelodysplasia. Acta Neurochir (Wien) 2001;143:909-918.
33. Klekamp J. The pathophysiology of syringomyelia: Historical overview and current concept. Acta Neurochir (Wien) 2002;144:649-664.
34. Nakamura M, Chiba K, Nishizawa T, et al. Retrospective study of surgery-related outcomes in patients with syringomyelia associated with Chiari I malformation: Clinical significance of changes in the size and localization of syrinx on pain relief. J Neurosurg 2004(3 Suppl Spine):241-244.
35. Todor DR, Harrison TM, Millport TH. Pain and syringomyelia: A review. Neurosurg Focus 2000;8:1-6.
36. Lu D, Lamb CR, Pfeiffer DU, et al. Neurological signs and results of magnetic resonance imaging in 40 cavalier King Charles Spaniels with Chiari type 1 like malformations. Vet Rec 2003;153:260-263.
37. Stanfa LC, Dickenson AH. In vivo electrophysiology of dorsal-horn neurons. Methods Mol Med 2004;99:139-153.
38. Milhorat TH, Mu HT, LaMotte CC, et al. Distribution of substance P in the spinal cord of patients with syringomyelia. J Neurosurg 1996;84:992-998.
39. Van Biervliet J, de Lahunta A, Ennulat D, et al. Acquired cervical scoliosis in six horses associated with dorsal grey column chronic myelitis. Equine Vet J 2004;36:86-92.
40. Loder RT, Stasikelis P, Farley FA. Sagittal profiles of the spine in scoliosis associated with an Arnold-Chiari malformation with or without syringomyelia. J Pediatr Orthop 2002;22:483-491.
41. Skerritt JO, Skerritt GC. Hearing status of the Cavalier King Charles Spaniel: A comparative study of healthy dogs and those suffering from Arnold Chiari syndrome. BSAVA Congress 2001 Scientific Proceedings, British Small Animal Veterinary Association, Woodrow House, 1 Telford Way, Waterwells Business Park, Quedgeley, Gloucester, 2001;567.
42. Munro KJ, Cox CL. Investigation of hearing impairment in Cavalier King Charles Spaniels using auditory brainstem response audiometry. J Am Anim Hosp Assoc 1997;38:2-5.
43. Kumar A, Patni AH, Charbel F. The Chiari I malformation and the neurotologist. Otol Neurotol 2002;23:727-735.
44. Milhorat TH, Chou MW, Trinidad EM, et al. Chiari malformation redefined: Clinical and radiographic findings for 363 symptomatic patients. Neurosurgery 1999;44:1005-1017.
45. Ventureyra EC, Aziz HA, Vassilyadi M. The role of cine flow MRI in children with Chiari I malformation. Childs Nerv Syst 2003;19:109-113.
46. March PA, Abramson CJ, Smith M, et al. CSF flow abnormalities in caudal occipital malformation syndrome. Scientific Proceedings from 23rd ACVIM Forum, Baltimore, American College of Veterinary Internal Medicine, Lakewood, CO. 2005; 854-855.
47. Levendoglu F, Ogun CO, Ozerbil O, et al. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine 2004;29:743-751.
48. Lindvall-Axelsson M, Nilsson C, Owman C, et al. Inhibition of cerebrospinal fluid formation by omeprazole. Exp Neurol 1992;115:394-399.
49. Javaheri S, Corbett WS, Simbartl LA, et al. Different effects of omeprazole and Sch 28080 on canine cerebrospinal fluid production. Brain Res 1997;754:321-324.
50. Berlin RG. Omeprazole. Gastrin and gastric endocrine cell data from clinical studies. Dig Dis Sci 1991;36:129-136.
51. Vogh BP. The relation of choroid plexus carbonic anhydrase activity to cerebrospinal fluid formation: Study of three inhibitors in cat with extrapolation to man. J Pharmacol Exp Ther 1980;213:321-331.
52. Shinnar S, Gammon K, Bergman EW Jr, et al. Management of hydrocephalus in infancy: Use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts. J Pediatr 1985;107:31-37.
53. Carrion E, Hertzog JH, Medlock MD, et al. Use of acetazolamide to decrease cerebrospinal fluid production in chronically ventilated patients with ventriculopleural shunts. Arch Dis Child 2001;84:68-71.
54. Artru AA, Powers KM. Furosemide decreases cerebrospinal fluid formation during desflurane anesthesia in rabbits. J Neurosurg Anesthesiol 1997;9:166-174.
55. Lorenzo AV, Hornig G, Zavala LM, et al. Furosemide lowers intracranial pressure by inhibiting CSF production. Z Kinderchir 1986;41(Suppl 1):10-12.
56. Pinegin LE, Dolzhenko DA, Natochin IuV. Mechanism of the decrease in intracranial pressure as affected by furosemide. Biull Eksp Biol Med 1984;98:682-685.
57. Simpson ST. Hydrocephalous. In: Kirk RW, ed. Current Veterinary Therapy X. Philadelphia: WB Saunders; 1989:842-847.
58. Vela AR, Carey ME, Thompson BM. Further data on the acute effect of intravenous steroids on canine CSF secretion and absorption. J Neurosurg 1979;50:477-482.
59. Wong HK, Tan KJ. Effects of corticosteroids on nerve root recovery after spinal nerve root compression. Clin Orthop 2002;403:248-252.
60. da Costa RC, Parent JM, Poma R, et al. Cervical syringohydromyelia secondary to a brainstem tumor in a dog. J Amer Vet Med Assoc 2004;225:1061-1064.
61. Churcher RK, Child G. Chiari 1/syringomyelia complex in a King Charles Spaniel. Aust Vet J 2000;78:92-95.
62. Vermeersch K, Van Ham, Caemaert J, et al. Suboccipital craniectomy, dorsal laminectomy of C1, durotomy and dural graft placement as a treatment for syringohydromyelia with cerebellar tonsil herniation in Cavalier King Charles Spaniels. Vet Surg 2004;33:355-360.
63. Dewy CW, Berg JM, Barone G, et al. Treatment of caudal occipital malformation syndrome in dogs by foramen magnum decompression. Scientific Proceedings from 23rd ACVIM Forum, Baltimore, American College of Veterinary Internal Medicine, Lakewood, CO, 2005;854.
64. Skerrit GC, Hughes D. A syndrome of syringomyelia in the cavalier King Charles spaniel, and its treatment by syringo-subarachnoid shunting. Proceedings from the 12th Annual Symposium of the European Society of Veterinary Neurology, Vienna September 25-26, 1998;23.
65. Schijman E, Steinbok P. International survey on the management of Chiari I malformation and syringomyelia. Childs Nerv Syst 2004;20:341-348.
66. Muraszko KM, Ellenbogen RG, Mapstone TB. Controversies in the surgical management of Chiari I malformations: What is the surgical procedure of choice? To open dura or not to open dura? Clin Neurosurg 2004;51:241-247.
67. Milhorat TH, Bolognese PA. Tailored operative technique for Chiari type I malformation using intraoperative color Doppler ultrasonography. Neurosurgery 2003;53:899-905.
68. Sacco D, Scott RM. Reoperation for Chiari malformations. Pediatr Neurosurg 2003;39:171-178.
69. Tubbs RS, McGirt MJ, Oakes WJ. Surgical experience in 130 pediatric patients with Chiari I malformations. J Neurosurg 2003;99:291-296.
70. Milhorat TH, Kotzen RM, Mu HT, et al. Dysesthetic pain in patients with syringomyelia. Neurosurgery 1996;38:940-946.